Treatment resistance is a common issue among schizophrenia patients undergoing antipsychotic treatment. According to the American Psychiatric Association (APA) guidelines, treatment-resistant status is defined as little or no symptom reduction to at least two antipsychotics at a therapeutic dose for a trial of at least six weeks. The aim of the current study is to determine whether ethnicity and migration are associated with treatment resistance.
The effect of ethnicity and immigration on treatment resistance in schizophrenia / Bani-Fatemi, Ali; Tasmim, Samia; Graff, Ariel; Gerretsen, Philip; Dada, Oluwagbenga O; Kennedy, James L; Hettige, Nuwan; Zai, Clement; de Jesus, Danilo; de Bartolomeis, Andrea; De Luca, Vincenzo. - In: COMPREHENSIVE PSYCHIATRY. - ISSN 0010-440X. - 89:(2019), pp. 28-32. [10.1016/j.comppsych.2018.12.003]
The effect of ethnicity and immigration on treatment resistance in schizophrenia
de Bartolomeis, AndreaMembro del Collaboration Group
;
2019
Abstract
Treatment resistance is a common issue among schizophrenia patients undergoing antipsychotic treatment. According to the American Psychiatric Association (APA) guidelines, treatment-resistant status is defined as little or no symptom reduction to at least two antipsychotics at a therapeutic dose for a trial of at least six weeks. The aim of the current study is to determine whether ethnicity and migration are associated with treatment resistance.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
